Efficacy of Inhaled Nitroglycerin in Moderate to Critically Ill COVID-19 Patients
NCT04686760
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
278
Enrollment
OTHER
Sponsor class
Conditions
Corona Virus Infection
Interventions
DRUG:
Nitroglycerin
Sponsor
University of Lahore